May 29, 2009 Unigene
Laboratories, Inc. (OTCBB: UGNE), (http:// www.unigene.com) has drawn
down the remaining $5,000,000 under its existing financing agreement
with Victory Park Management,...
Unigene Biotechnology Co. Ltd. Facilities to Perform Research,
Development, Formulation and Manufacturing
First Phase of Construction to be Completed in 2008, Production and...
Unigene Laboratories, Inc. (OTCBB: UGNE) reports that a comparative analysis of various osteoporosis therapies has been published, concluding that there is insufficient evidence to support claims...
FAIRFIELD, N.J.--(BUSINESS WIRE)--The site-directed bone growth (SDBG) technology currently being developed by Unigene Laboratories, Inc. (OTCBB: UGNE) in conjunction with Yale...
FAIRFIELD, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc. (OTCBB: UGNE) announced its financial results for December 31, 2006. Revenue for the three months ended December 31,...
FAIRFIELD, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc. (OTCBB: UGNE) will release financial results for the year ended December 31, 2006, before the market opens on Monday, March...
FAIRFIELD, N.J.--(BUSINESS WIRE)--The initiation of a Phase III clinical study for osteoporosis by Nordic Bioscience, the development partner of Novartis Pharma AG, with oral calcitonin...
FAIRFIELD, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc. (OTCBB: UGNE) has been awarded a Phase II Small Business Innovative Research (SBIR) Grant from the National Institute for...
FAIRFIELD, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc. (OTCBB: UGNE) has engaged two leading
clinicians as consultants to assist in the development and testing
relating to the...
FAIRFIELD, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc. (OTCBB: UGNE) announced its financial results
for September 30, 2006.
Revenue for the three months ended...
FAIRFIELD, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc. (OTCBB: UGNE) will release financial results
for the third quarter ended September 30, 2006, before the market opens
on...
FAIRFIELD, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc.’s (OTCBB: UGNE)
President and CEO, Dr. Warren Levy, will speak at the 8th
Annual Rodman and Renshaw Healthcare...
FAIRFIELD, N.J.--(BUSINESS WIRE)--Sept. 19, 2006--Unigene Laboratories, Inc.'s (OTCBB: UGNE) President and CEO, Dr. Warren Levy, will speak at the 8th Annual UBS Global Life Sciences Conference on...
FAIRFIELD, N.J.--(BUSINESS WIRE)--Aug. 30, 2006--Unigene Laboratories, Inc.'s (OTCBB: UGNE) President and CEO, Dr. Warren Levy, will speak at the 4th Annual ThinkEquity Partners Conference on...
FAIRFIELD, N.J.--(BUSINESS WIRE)--Aug. 11, 2006--Unigene Laboratories, Inc. (OTCBB: UGNE) has been named to Deloitte's prestigious Technology Fast 50 Program for New Jersey. It was ranked ninth out...
